Filing Details

Accession Number:
0001213900-25-023834
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-13 21:40:50
Reporting Period:
2024-11-01
Filing Date:
2025-03-13
Accepted Time:
2025-03-13 21:40:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1771706 Vireo Growth Inc. VREO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1862016 Chicago Atlantic Credit Opportunities, Llc 420 North Wabash Avenue, Suite 500
Chicago IL 60611
No No Yes No
1915697 Chicago Atlantic Advisers, Llc 420 North Wabash Avenue
Suite 500
Chicago IL 60611
No No Yes No
1985010 Chicago Atlantic Group Gp, Llc 420 N Wabash Ave Ste 500
Chicago IL 60611
No No Yes No
1985014 Chicago Atlantic Group, Lp 420 N Wabash Ave Ste 500
Chicago IL 60611
No No Yes No
1985176 Chicago Atlantic Gp Holdings, Llc 420 N Wabash Ave Ste 500
Chicago IL 60611
No No Yes No
1985178 Chicago Atlantic Manager, Llc 420 N Wabash Ave Ste 500
Chicago IL 60611
No No Yes No
2027100 Chicago Atlantic Opportunity Portfolio, Lp 420 North Wabash Avenue
Suite 500
Chicago IL 60611
No No Yes No
2027156 Chicago Atlantic Opportunity Gp, Llc 420 North Wabash Avenue
Suite 500
Chicago IL 60611
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Subordinate Voting Shares Acquisiton 2025-03-07 2,000 $0.35 2,000 No 4 P Direct
Subordinate Voting Shares Acquisiton 2025-03-11 70,000 $0.32 72,000 No 4 P Direct
Subordinate Voting Shares Acquisiton 2025-03-12 78,500 $0.34 150,500 No 4 P Direct
Subordinate Voting Shares Acquisiton 2025-03-13 40,000 $0.37 190,500 No 4 P Direct
Subordinate Voting Shares Acquisiton 2024-12-30 32,032,000 $0.63 110,362,683 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Subordinate Voting Shares Convertible Note (right to buy) Acquisiton 2024-11-01 0 $10,000,000.00 16,000,000 $0.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-11-01 2027-11-01 No 4 P Indirect
Footnotes
  1. The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.35035 to $0.35110, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4.
  2. The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.31400 to $0.33550, inclusive.
  3. The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.32060 to $0.35040, inclusive.
  4. The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.35400 to $0.37400, inclusive.
  5. Chicago Atlantic Group GP, LLC is the general partner of Chicago Atlantic Group, LP ("CAG") which is the managing member of Chicago Atlantic Advisers, LLC which is the investment manager of Chicago Atlantic Credit Opportunities, LLC ("CACO") and Chicago Atlantic Opportunity Portfolio, LP ("CAOP"). Chicago Atlantic GP Holdings, LLC ("CAGPH") is the managing member of Chicago Atlantic Manager, LLC ("CAM") which is the managing member of CACO. CAGPH is also the sole member of Chicago Atlantic Opportunity GP, LLC which is the general partner of CAOP. CAG is also the managing member of Chicago Atlantic Credit Company, LLC ("CACC"). The shares reported as indirectly held by CACO are held directly by CACC and CAOP. The address for all filing persons is set forth in Box 1. The reporting persons disclaim beneficial ownership of all reported securities except to the extent of their pecuniary interest therein, if any.
  6. The shares were purchased by a limited liability company managed by a CAG affiliate and whose members include CAG affiliates, as well as unaffiliated investors. The full purchase amount is reported; however, the reporting persons disclaim beneficial ownership of all reported securities except to the extent of their pecuniary interest therein, if any.
  7. The convertible notes were purchased by a limited liability company managed by a CAG affiliate and whose members include CAG affiliates, as well as unaffiliated investors. The full principal amount of the convertible note is reported; however, the reporting persons disclaim beneficial ownership of all reported securities except to the extent of their pecuniary interest therein, if any.